These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4026 related articles for article (PubMed ID: 10638568)
41. Chronic gastritis and Helicobacter pylori infection in University College Hospital Ibadan, Nigeria--a study of 85 fibre optic gastric biopsies. Oluwasola AO; Ogunbiyi JO Niger J Med; 2004; 13(4):372-8. PubMed ID: 15523864 [TBL] [Abstract][Full Text] [Related]
42. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Satoh K; Kimura K; Taniguchi Y; Kihira K; Takimoto T; Saifuku K; Kawata H; Tokumaru K; Kojima T; Seki M; Ido K; Fujioka T Am J Gastroenterol; 1998 Apr; 93(4):569-73. PubMed ID: 9576449 [TBL] [Abstract][Full Text] [Related]
43. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964 [TBL] [Abstract][Full Text] [Related]
44. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Floreani A; Biagini MR; Zappalà F; Farinati F; Plebani M; Rugge M; Surrenti C; Naccarato R Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572 [TBL] [Abstract][Full Text] [Related]
45. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266 [TBL] [Abstract][Full Text] [Related]
46. Type III intestinal metaplasia, Helicobacter pylori infection and gastric carcinoma risk index in an Italian series of 1750 patients. Suriani R; Venturini I; Taraglio S; Mazzucco D; Grosso S; Predebon S; Mamo C; Tremosini S; Ballesini P; Borghi A; Zeneroli ML Hepatogastroenterology; 2005; 52(61):285-8. PubMed ID: 15783051 [TBL] [Abstract][Full Text] [Related]
47. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. Yoo JY; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee HS; Choe C; Lee DH; Jung HC; Song IS J Clin Gastroenterol; 2007 Sep; 41(8):751-5. PubMed ID: 17700423 [TBL] [Abstract][Full Text] [Related]
48. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Prinz C; Schöniger M; Rad R; Becker I; Keiditsch E; Wagenpfeil S; Classen M; Rösch T; Schepp W; Gerhard M Cancer Res; 2001 Mar; 61(5):1903-9. PubMed ID: 11280745 [TBL] [Abstract][Full Text] [Related]
49. Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis. Pasechnikov VD; Chukov SZ; Kotelevets SM; Chabannaya TA Rocz Akad Med Bialymst; 2005; 50():183-7. PubMed ID: 16358962 [TBL] [Abstract][Full Text] [Related]
50. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005 [TBL] [Abstract][Full Text] [Related]
51. Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum. Hsu PI; Lai KH; Tseng HH; Lin CK; Lo GH; Cheng JS; Chan HH; Hsu JH; Jou HS; Ger LP; Chen W; Hsu PN Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):279-87. PubMed ID: 10820906 [TBL] [Abstract][Full Text] [Related]
52. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Lahner E; Bordi C; Cattaruzza MS; Iannoni C; Milione M; Delle Fave G; Annibale B Aliment Pharmacol Ther; 2005 Sep; 22(5):471-81. PubMed ID: 16128686 [TBL] [Abstract][Full Text] [Related]
53. Effect of Helicobacter pylori infection, age and epithelial cell turnover in a general population at high risk for gastric cancer. Baldini L; Pretolani S; Bonvicini F; Miglio F; Epifanio G; Gentiloni Silveri N; Stefanelli ML; Bernardi M; Gasbarrini G Panminerva Med; 1999 Sep; 41(3):187-92. PubMed ID: 10568114 [TBL] [Abstract][Full Text] [Related]
54. Geographic pathology of Helicobacter pylori gastritis. Liu Y; Ponsioen CI; Xiao SD; Tytgat GN; Ten Kate FJ Helicobacter; 2005 Apr; 10(2):107-13. PubMed ID: 15810940 [TBL] [Abstract][Full Text] [Related]
55. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Satoh K; Kimura K; Takimoto T; Kihira K Helicobacter; 1998 Dec; 3(4):236-40. PubMed ID: 9844064 [TBL] [Abstract][Full Text] [Related]
56. Follicular gastritis associated with Helicobacter pylori. Ma ZQ; Tanizawa T; Nihei Z; Sugihara K; Nakamura K J Med Dent Sci; 2000 Mar; 47(1):39-47. PubMed ID: 12162525 [TBL] [Abstract][Full Text] [Related]
57. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis. Teh M; Tan KB; Seet BL; Yeoh KG Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741 [TBL] [Abstract][Full Text] [Related]
58. [Effect of eradication treatment on histological changes of the gastric mucosa in patients with non-ulcer dyspesia and Helicobacter pylori infection. Randomized prospective study]. Kyzeková J Vnitr Lek; 1999 Feb; 45(2):90-6. PubMed ID: 15641227 [TBL] [Abstract][Full Text] [Related]
59. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H Digestion; 2007; 75(1):54-61. PubMed ID: 17438355 [TBL] [Abstract][Full Text] [Related]
60. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]